BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27101149)

  • 1. The role of the Chaperonin containing t-complex polypeptide 1, subunit 8 (CCT8) in B-cell non-Hodgkin's lymphoma.
    Yin H; Miao X; Wu Y; Wei Y; Zong G; Yang S; Chen X; Zheng G; Zhu X; Guo Y; Li C; Chen Y; Wang Y; He S
    Leuk Res; 2016 Jun; 45():59-67. PubMed ID: 27101149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
    Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
    Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
    Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
    Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.
    Huang X; Wang X; Cheng C; Cai J; He S; Wang H; Liu F; Zhu C; Ding Z; Huang X; Zhang T; Zhang Y
    APMIS; 2014 Nov; 122(11):1070-9. PubMed ID: 24862099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.
    Zhu X; Miao X; Wu Y; Li C; Guo Y; Liu Y; Chen Y; Lu X; Wang Y; He S
    Exp Cell Res; 2015 Jul; 335(2):216-23. PubMed ID: 26024773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.
    Qiu X; He X; Huang Q; Liu X; Sun G; Guo J; Yuan D; Yang L; Ban N; Fan S; Tao T; Wang D
    Pathol Res Pract; 2015 Oct; 211(10):717-25. PubMed ID: 26304164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
    Tedoldi S; Paterson JC; Cordell J; Tan SY; Jones M; Manek S; Dei Tos AP; Roberton H; Masir N; Natkunam Y; Pileri SA; Facchetti F; Hansmann ML; Mason DY; Marafioti T
    J Pathol; 2006 Aug; 209(4):454-63. PubMed ID: 16739114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
    Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
    Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
    Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
    Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in vitro and in vivo.
    Cooper AC; Karp RM; Clark EJ; Taghizadeh NR; Hoyt JG; Labenski MT; Murray MJ; Hannig G; Westlin WF; Thompson CD
    Clin Cancer Res; 2006 Apr; 12(8):2583-90. PubMed ID: 16638869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).
    Wang Y; Huang Y; Xu X; Tang J; Huang X; Zhu J; Liu J; Miao X; Wu Y; Yang F; Ji L; He S
    Leuk Res; 2014 Aug; 38(8):955-63. PubMed ID: 24974147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
    Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
    Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
    Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
    J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin's lymphoma].
    Wu YX; He S; Xu XH
    Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):668-673. PubMed ID: 30180469
    [No Abstract]   [Full Text] [Related]  

  • 17. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
    Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
    Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.